Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00185419
Status:
COMPLETED
Last Update Posted:
2009-01-14
First Post:
2005-09-13
Brief Title:
A Clinical Study on Yasmin vs Marvelon in Chinese Women Requiring Contraception
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
An Open-Label Randomised Parallel-Group Comparison to Investigate the Efficacy of Yasmin 30 µg Ethinylestradiol 3mg Drospirenone and Marvelon 30 µg Ethinylestradiol 150 µg Desogestrel on Cycle Control in Healthy Chinese Women Over 13 Cycles
Status:
COMPLETED
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the effectiveness in terms of prevention of pregnancy and safety of the oral contraceptive Yasmin and Marvelon on cycle control in healthy Chinese women
Detailed Description:
The study has previously been posted by Schering AG Germany Schering AG Germany has been renamed to Bayer Schering Pharma AG Germany
Bayer Schering Pharma AG Germany is the sponsor of the trial
Bayer Schering Pharma AG Germany is the sponsor of the trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 308062 | None | None | None |